CME Stock Price Today (September 2026) — CME Group Inc. Analysis & Key Metrics 2026-09-03
CME Group Inc. (CME) is trading at $282.05, up 1.54% today (as of September 2026). The stock continues to show sustained strength above key moving averages, attracting attention from investors looking for Financial Services growth opportunities.
- According to consensus analyst estimates, the 1-year price target is $283.93 (0.7% upside).
- Volatility remains elevated (19.27% annualized), implying wide price swings for short-term traders.
- The fundamental picture, based on the latest financial filings, is nuanced: solid revenue growth (80.00% YoY) alongside significant competitive pressures.
CME Stock Analysis: Key Metrics & Valuation (September 2026)
Concise, actionable data for investors
CME Group Inc. - Historical Price & Volume
Market Cap
Enterprise Value: $104.36B
P/E Ratio
Forward P/E: 22.08
Revenue Growth
Year over Year
Analyst Target
+0.7% upside potential
Key Investor Questions About CME
What investors need to know before buying
Based on current market data, CME presents a neutral technical setup with caution warranted fundamentals.
- Technicals say: Neutral (RSI 60.70)
- Fundamentals say: Caution warranted (high leverage concerns)
CME's growth trajectory depends on its ability to expand within the Financial Data & Stock Exchanges sector while managing margin pressures.
- Future growth will depend on performance in core Financial Data & Stock Exchanges operations.
- The ability to manage competitive pressures will be crucial for sustained growth.
The primary risks for CME investors include debt exposure and competitive dynamics in the Financial Data & Stock Exchanges industry.
- $3.87B in debt could be a headwind in a high-rate environment.
- Fierce competition from established players in Financial Data & Stock Exchanges.
52-Week Trading Range
Over the past year, CME stock traded between $218.31 and $329.16—recovering meaningfully from lows and currently near the higher end. Big swings are likely unless a major catalyst emerges.
Volatility & Risk Profile
With 19.27% annualized volatility and β=-0.14, the stock exhibits low sensitivity to market moves—making CME suitable for investors comfortable with active risk management.
Institutional & Insider Ownership
High institutional backing, but elevated short interest signals a potential battleground stock.
Analyst Sentiment & Price Targets
Latest News & Headlines
Recent headlines and coverage
Fed Rate Hike Odds Fall to 50/50: Will Bitcoin's Rally Above 80,000 Hold?
CME FedWatch odds for a September Fed rate hike fell to 50/50 Friday as Bitcoin extended its rally toward $82,000.
Bitcoin Climbs to Highest Intraday Level Since May as Risk Assets Get Boost From Waller’s Comments
The price of the world’s most well-known cryptocurrency surged along with major stock indexes Thursday.
Trump Wants Lower Rates. That Won’t Stop a Fed Rate Hike.
President Donald Trump says the U.S. “should have the lowest interest rates in the world.” But he appears to be giving Fed Chair Kevin Warsh breathing room for now.
Morning Bid: Bonds breathe sigh of relief
A look at the day ahead in European and global markets from Rocky Swift Battered bond markets licked their wounds on Thursday, with yields in the U.S. and Japan edging lower, but little has changed to
Hyperliquid's HYPE Joins Hashdex Crypto ETF as Fifth-Largest Holding
HYPE joins Hashdex's NCIQ crypto ETF at a 3.4% weighting, becoming its fifth-largest holding as Bitcoin's share dips.
Trump Wants Lower Rates. That Won’t Stop a Fed Rate Hike.
President Donald Trump says the U.S. “should have the lowest interest rates in the world.” But he appears to be giving Fed Chair Kevin Warsh breathing room for now.
A Macro Storm Is Threatening Stocks. Corporate Earnings Can’t Stop It.
Great earnings are now old news. The next market hurdles are the jobs report, CPI, and the Fed’s rate decision.
Odds of Fed Rate Hike in September Hit 70%
Investors are now pricing in a 70% chance that the Federal Reserve raises rates at its Sept. 15-16 meeting. That is up from 37% a week ago, according to CME Group data. The jump in rate expectations is a major driver behind the rise in U.
Best Leveraged ETFs of Last Week
Leveraged ETFs surged last week as strong earnings lifted Salesforce and Okta, while declines in AXT and D-Wave boosted inverse ETFs.
Will CME’s New Factor and Wind Power Futures Suite Change CME Group’s (CME) Narrative?
CME Group recently broadened its derivatives lineup by announcing E-mini Equity Factor futures and financially settled Wind Power futures and options, aimed at giving investors more targeted tools for managing equity factor exposures and wind generation risk across major global regions. By moving into both factor-based equity contracts and weather-linked power instruments, CME Group is extending futures-style hedging into increasingly specialized corners of portfolio construction and the...
Explore More Analysis for CME
Additional research, tools, and technical breakdowns
Stock Analyzer Report
Deep-dive automated research and stock rating report.
DCF Fair Value Calculator
Discounted cash flow model and intrinsic value projection.
AI Price Predictions
Multi-scenario price predictions and consensus targets.
Insider Activity Tracker
Track buying/selling behavior of corporate insiders.
Earnings Calendar
Track upcoming and historical corporate earnings reports.
Market Insights & Research
Read the latest analysis articles and expert research.
Frequently Asked Questions
Common investor questions about CME Group Inc.
CME Group Inc. (CME) is currently trading at $282.05. The RSI (14-day) is at 60.7, indicating neutral territory. Wall Street analysts have a consensus "buy" recommendation. The mean analyst price target of $283.93 implies 0.7% upside from current levels. Volatility is low at 19.3% annualized, meaning price movements are relatively contained. Investors should consider their risk tolerance, investment horizon, and portfolio diversification before making a decision.
Based on current valuation metrics for CME Group Inc. (CME): The trailing P/E ratio is 23.90, which is in line with broader market averages. The forward P/E is 22.08, lower than the trailing P/E, suggesting analysts expect earnings improvement. The PEG ratio is 4.93, above 2.0, suggesting the stock may be overvalued relative to its expected growth. Price-to-Book is 3.82. Price-to-Sales is 15.01. Valuation should be compared to Financial Data & Stock Exchanges industry peers for context, as different sectors trade at different multiples.
Based on 15 analysts covering CME, the consensus price target is $283.93. This represents a 0.7% upside from the current price of $282.05. The range spans from a low target of $230.00 to a high target of $330.00, reflecting varying levels of optimism among analysts. The consensus recommendation is "buy". Note: Analyst price targets are forward-looking estimates and not guarantees of future performance.
Yes, CME Group Inc. (CME) pays a dividend with a current yield of approximately 1.84%. The annualized dividend rate is $5.10 per share. The payout ratio is 95.4%, which is relatively high—earnings cover the dividend but there's limited room for increases. The most recent ex-dividend date was 2026-09-09T00:00:00.000Z.
Key risks for CME Group Inc. (CME) investors include: 1. Broader market and macroeconomic risks (interest rates, inflation, geopolitical events). 2. Financial Data & Stock Exchanges sector-specific competitive pressures. Investors should diversify and consider their risk tolerance before investing.
Here is CME Group Inc.'s (CME) current debt and financial health profile: Total debt stands at $3.87B. The debt-to-equity ratio is 14.59, which is conservative and indicates a strong balance sheet with low leverage. The current ratio is 1.02, indicating adequate short-term liquidity. The quick ratio is 0.02. The company holds $2.28B in cash and equivalents. Free cash flow is positive at $2.91B, providing a cushion for debt servicing and shareholder returns.